Original Research
Published on 07 Dec 2022
Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1022131
- 1,756 views
- 3 citations
Type at least 3 characters
1,029 articles
Articles
Original Research
Published on 07 Dec 2022
Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1063057
- 2,484 views
- 11 citations
Original Research
Published on 07 Dec 2022
Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1004467
- 2,977 views
- 1 citation
Original Research
Published on 06 Dec 2022
A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.938250
- 2,483 views
- 2 citations
Original Research
Published on 06 Dec 2022
Construction and validation of a novel cuproptosis-related long noncoding RNA signature for predicting the outcome of prostate cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.976850
- 2,994 views
- 4 citations
Original Research
Published on 06 Dec 2022
Identification of hub genes correlated with tumor-associated M1-like macrophage infiltration in soft tissue sarcomas
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.999966
- 2,034 views
- 2 citations
Original Research
Published on 05 Dec 2022
Development of dynamical network biomarkers for regulation in Epstein-Barr virus positive peripheral T cell lymphoma unspecified type
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.966247
- 1,807 views
Original Research
Published on 05 Dec 2022
EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1058207
- 2,394 views
- 3 citations
Original Research
Published on 02 Dec 2022
T cell exhaustion assessment algorism in tumor microenvironment predicted clinical outcomes and immunotherapy effects in glioma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1087434
- 3,001 views
- 2 citations
Original Research
Published on 02 Dec 2022
Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1036098
- 3,519 views
- 7 citations
Original Research
Published on 02 Dec 2022
m7G-related lncRNAs are potential biomarkers for predicting prognosis and immune responses in patients with oral squamous cell carcinoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1013312
- 2,388 views
- 4 citations
Original Research
Published on 01 Dec 2022
Identification and validation of a prognostic model based on ferroptosis-associated genes in head and neck squamous cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1065546
- 3,082 views
- 6 citations
Review
Published on 01 Dec 2022
The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.933475
- 5,939 views
- 4 citations
Review
Published on 30 Nov 2022
Epigenetics and genetics of hepatoblastoma: Linkage and treatment
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1070971
- 4,207 views
- 9 citations
Original Research
Published on 30 Nov 2022
Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.981145
- 2,504 views
- 1 citation
Original Research
Published on 30 Nov 2022
An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.1052092
- 1,576 views
- 3 citations